Subscribe to RSS
DOI: 10.1055/s-0043-1774323
Plantar Psoriasis Treated with Individualised Homoeopathic Medicine – A Case Report
Abstract
Psoriasis is a common non-infectious disease that is considered a chronic autoimmune condition. It is T-cell mediated and characterized by the rapid replacement of epidermal cells on the basal membrane level. Affecting approximately 2 to 3% of the population, around 3 to 4% of individuals with psoriasis experience palmoplantar psoriasis. This type of psoriasis can manifest at any age. Psoriasis, being a chronic skin disorder, impacts various aspects of an individual's social life. Homoeopathy has demonstrated positive outcomes in treating skin complaints. In this presentation, we discuss a diagnosed case of plantar psoriasis that was managed with individualized homoeopathic medicine. The patient exhibited itching eruptions on both soles, characterized by chronic local dryness, hardness, cracking, and roughness, without any other accompanying systemic complaints. This condition was treated using individualized homoeopathic medicine. The patient displayed significant improvement with the prescribed medicine, achieving full recovery within 6 months. The treatment comprised two doses of Sulphur 30 at a 1-month interval, followed by one dose of Sulphur 200 at a 4-month interval. Notably, there was no relapse for over 2 years, indicating that the benefits of the therapy persisted long after the treatment concluded. An assessment of possible causal attribution was conducted using the Modified Naranjo Criteria (Score-7 out of 13). Photographic documentation was conducted at the beginning and conclusion of the treatment. The negative impact of this chronic condition on the patients' quality of life was evaluated through the Dermatology Life Quality Index and was significantly ameliorated with homoeopathic treatment.
Declaration of Patient Consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published, and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed.
Publication History
Article published online:
06 October 2023
© 2023. Thieme. All rights reserved.
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Kumar B, Saraswat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 2002; 82 (03) 192-195
- 2 Asumalahti K, Ameen M, Suomela S. et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003; 120 (04) 627-632
- 3 Kingo K, Mössner R, Kõks S. et al. Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol 2007; 156 (04) 646-652
- 4 Coto-Segura P, González-Fernández D, Batalla A. et al. Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis. Br J Dermatol 2016; 175 (01) 134-141
- 5 Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci 2019; ;5; 20 (18) 4347
- 6 Farley E, Masrour S, McKey J, Menter A. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 2009; 60 (06) 1024-1031
- 7 Menter A, Korman NJ, Elmets CA. et al; American Academy of Dermatology Work Group. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65 (01) 137-174
- 8 Pathirana D, Ormerod AD, Saiag P. et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009 Oct;23 suppl 2: 1-70 DOI: 10.1111/j.1468-3083.2009.03389.x.
- 9 Boericke W. Pocket Manual of Homoeopathic Materia Medica, 9th ed. New Delhi: IBPP; 2015
- 10 Signore RJ. Classic homeopathic medicine and the treatment of eczema. Cosm Derm J 2011; 24: 420-425
- 11 Nwabudike LC, Miulescu M, Tatu AL. Case series of an alternative therapy for generalised lichen planus: four case studies. Exp Ther Med 2019; 18 (02) 943-948
- 12 Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with psoriasis – a prospective observational study with 2 years follow-up JEADV. 2009; 23: 538-543
- 13 Nwabudke LC. Psoriasis and homeopathy. Proc Rom Acad Series B. 2011; 3: 237-242
- 14 Chitale A, Alekar A, Sinnarkar V. Efficacy of Constitutional Prescription in Homoeopathic Management of Psoriasis: Case Report. Altern Ther Health Med 2023; May; 29 (04) 280-283 . PMID: 34936989
- 15 Hahnemann S. Organon of Medicine. Low Price Edition.. New Delhi: B. Jain Publishers; 2002. :Aphorism:189–90103–5
- 16 Finlay AK, Khan GK. Dermatology Quality of Life Index (DQLI). [Internet]. 1991 Apr [Cited 2019 Feb 2]. Accessed August 22, 2023 at: http://sites.cardiff.ac.uk/dermatology/quality-of-life/dermatologyquality-of-life-index-dlqi/
- 17 Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132 (02) 236-244
- 18 Schroyens F. Synthesis Treasure edition 2099V software version Radar opus 3.0.16- License: 122928
- 19 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109 (04) 191-197
- 20 Jensen P. Alternative therapy for atopic dermatitis and psoriasis: patient-reported motivation, information source and effect. Acta Derm Venereol 1990; 70 (05) 425-428
- 21 Rahman S, Dey J. A case report of plantar psoriasis treated with homoeopathy. Homoeopath Links 2018; 31: 248-253
- 22 Nwabudike LC. Palmar and plantar psoriasis and homeopathy – case reports. Our Dermatol Online 2017; 8 (01) 66-69